Correlation Between LMF Acquisition and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both LMF Acquisition and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LMF Acquisition and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LMF Acquisition Opportunities and Revelation Biosciences, you can compare the effects of market volatilities on LMF Acquisition and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LMF Acquisition with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of LMF Acquisition and Revelation Biosciences.
Diversification Opportunities for LMF Acquisition and Revelation Biosciences
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between LMF and Revelation is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding LMF Acquisition Opportunities and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and LMF Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LMF Acquisition Opportunities are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of LMF Acquisition i.e., LMF Acquisition and Revelation Biosciences go up and down completely randomly.
Pair Corralation between LMF Acquisition and Revelation Biosciences
Assuming the 90 days horizon LMF Acquisition is expected to generate 1.39 times less return on investment than Revelation Biosciences. In addition to that, LMF Acquisition is 1.36 times more volatile than Revelation Biosciences. It trades about 0.09 of its total potential returns per unit of risk. Revelation Biosciences is currently generating about 0.18 per unit of volatility. If you would invest 30.00 in Revelation Biosciences on October 24, 2024 and sell it today you would earn a total of 10.00 from holding Revelation Biosciences or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
LMF Acquisition Opportunities vs. Revelation Biosciences
Performance |
| Timeline |
| LMF Acquisition Oppo |
| Revelation Biosciences |
LMF Acquisition and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LMF Acquisition and Revelation Biosciences
The main advantage of trading using opposite LMF Acquisition and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LMF Acquisition position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| LMF Acquisition vs. LMF Acquisition Opportunities | LMF Acquisition vs. Cardio Diagnostics Holdings | LMF Acquisition vs. Revelation Biosciences |
| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets |